Answers are grounded in this paper and cite their sources.
This analysis examines pharmacist interventions on drug-related problems (DRPs) in cancer patients, suggesting improvements for pharmaceutical services.
Cancer has been a global health issue. In 2018, cases related to cancer reached 18.1 million and the number of cancer-related deaths was 9.6 million. Pharmacists, play a crucial role in preventing and addressing Drug-Related Problems (DRPs) through pharmaceutical services. This research aims to examine the overview of Drug-Related Problems (DRPs) in inpatient cancer patients undergoing chemotherapy and to define the pharmacist's interventions regarding DRPs in cancer patients at RSUP Dr. Kariadi Semarang. This study employed a retrospective data collection approach. The materials were obtained from pharmacist prescription reviews and the medical records of cancer inpatients undergoing chemotherapy in January 2022. The classification of Drug-Related Problems (DRPs) followed PCNE V9.1 guidelines. A total of 239 DRPs were identified. The main issues were related to treatment effectiveness (44%), treatment safety (43.9%), and others (12.1%). Common causes of DRPs included dosing selection (63.7%), drug selection (28.4%), and treatment duration (0.4%). Pharmacists' interventions were carried out at the prescription writing level in 376 cases (61.4%) and at the drug utilization level in 294 cases (38.6%). The verification of prescriptions by clinical pharmacists before drug preparation is a crucial step to reduce the potential occurrence of DRPs
No takes yet. Share an insight, caveat, or question.
Permatasari et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: